Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Demyelination and Neurodegeneration in Multiple Sclerosis: The Role of Hypoxia.
Perceived cognitive decline in multiple sclerosis impacts quality of life independently of depression.
Transglutaminase 2 and neuroinflammation.
cFLIP is critical for oligodendrocyte protection from inflammation.
Mesenchymal Stem Cells and Induced Pluripotent Stem Cells as Therapies for Multiple Sclerosis.
Breast regression protein-39 is not required for experimental autoimmune encephalomyelitis induction.
Similar genetics of adult and pediatric MS: Age is just a number.
Modulation of subventricular zone oligodendrogenesis: a role for hemopressin?
The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.
Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis.
Activity-dependent regulation of excitable axonal domains.
Pain and spinal cord imaging measures in children with demyelinating disease.
New-onset multiple sclerosis associated with adalimumab treatment in rheumatoid arthritis: a case report and literature review.
Next-generation sequencing in understanding complex neurological disease.
Understanding tremor in multiple sclerosis: prevalence, pathological anatomy, and pharmacological and surgical approaches to treatment.
Identity-by-Descent Mapping to Detect Rare Variants Conferring Susceptibility to Multiple Sclerosis.
Progressive multifocal leukoencephalopathy in patients with multiple sclerosis.
[NMO Spectrum Disorders and Anti AQP4 Antibody].
Reliability of Longitudinal Brain Volume Loss Measurements between 2 Sites in Patients with Multiple Sclerosis: Comparison of 7 Quantification Techniques.
MCAM(+) CD8 T lymphocytes mediate CNS inflammation.
Knee muscle strength in multiple sclerosis: relationship with gait characteristics.
The Parallel Analysis of Phase Sensitive Inversion Recovery (PSIR) and Double Inversion Recovery (DIR) Images Significantly Improves the Detection of Cortical Lesions in Multiple Sclerosis (MS) since Clinical Onset.
Multiple sclerosis in 2015: Managing the complexity of multiple sclerosis.
Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohort.
Pages
« first
‹ previous
…
342
343
344
345
346
347
348
349
350
…
next ›
last »